US 7,611,694 B2Granted

Aerosol formulation for inhalation comprising an anticholinergic

AssigneeBoehringer Ingelheim Pharma GmbH & Co. KG

InventorFriedrich Schmidt

Life of this patent

Estimating the term…

The present invention relates to a propellant-free, aqueous aerosol formulation for anticholinergics of formula 1 wherein X− denotes an anion.

Dependent claims

An propellant-free aqueous pharmaceutical formulation for inhalation comprising at least one compound of formula 1 as the only active substance

wherein
X− is an anion selected from the group consisting of chloride, bromide, iodide, sulphate, phosphate, methanesulphonate, nitrate, maleate, acetate, citrate, fumarate, tartrate, oxalate, succinate, benzoate and p-toluenesulphonate,
at least one pharmacologically acceptable acid and water, which formulation is a liquid.

Dependencies are inferred from the claim text.

A61K 9/0078
Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy: for inhalation via a nebulizer…
A61K 31/33
Medicinal preparations containing organic active ingredients: heterocyclic compounds
A61K 31/4745
Ortho- or peri-condensed with heterocyclic ring systems: condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
A61K 31/5375
Having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines: 1,4-Oxazines, e.g. morpholine

From the US filing history. Foreign family members aren’t listed.

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

Loading patent…

The present invention relates to a propellant-free, aqueous aerosol formulation for anticholinergics of formula 1 wherein X− denotes an anion.

Facts

Application

11/424,541Filed 15 Jun 2006 · continuation

Priority

DE 102 37 23214 Aug 2002

Published

US 2006/0222598 A15 Oct 2006

Granted

3 Nov 2009

Term ends

Not estimatedThe source records don’t support an estimate.

A61K 9/0078
Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy: for inhalation via a nebulizer…
A61K 31/33
Medicinal preparations containing organic active ingredients: heterocyclic compounds
A61K 31/4745
Ortho- or peri-condensed with heterocyclic ring systems: condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
A61K 31/5375
Having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines: 1,4-Oxazines, e.g. morpholine

Family

Application60/415,852Us provisional application · filed 3 Oct 2002

Application10/637,769Parent of this continuation · filed 8 Aug 2003

US 2006/0222598 A1Pre-grant publication · published 5 Oct 2006

US 2004/0166065 A1Published application

US 7,611,694 B2This patent

From the US filing history. Foreign family members aren’t listed.